Restoring Synaptic Architecture
The Future of
Neurological Therapeutics
Starts with Connection.
WYYS is developing a new class of antibody therapeutics designed to restore synaptic architecture and support functional recovery in neurological diseases.
Synaptic Dysfunction
Different disorders.
A shared vulnerability.
Many neurological disorders converge on synaptic dysfunction.
Dysfunction
Our Approach
Treating the connection,
not only the pathology.
Current disease-modifying strategies often focus on pathological proteins. WYYS is developing a complementary therapeutic approach that directly addresses synaptic dysfunction by restoring synaptic architecture and supporting functional recovery.
The 3R Philosophy
Reconnect. Restore. Recover.
Three principles. One therapeutic direction.
Reconnect.
Re-establish the structural relationships required for effective neuronal communication.
Restore.
Support the organization and stability of synaptic architecture.
Recover.
Enable the conditions required to support meaningful neurological function.
Our Platform
Engineering Antibody Therapeutics
for Synaptic Connectivity.
A synapse-focused antibody platform designed to restore synaptic architecture and support functional connectivity.
Development
Advancing from hypothesis
toward experimental validation.
Our platform combines scientific rationale, structural biology, computational protein design and molecular simulation to move therapeutic concepts toward recombinant development and biological validation.
About WYYS
From Neural Plasticity
to Synaptic Therapeutics.
WYYS was founded by Hajun Yoon, MD, a physician whose work has spanned neuroscience research, clinical practice, structural biology, antibody engineering, computational protein design and molecular simulation.
WYYS was created to pursue a simple scientific question: could restoring synaptic architecture become a new therapeutic strategy for neurological disease?